Welcure Drugs & Pharmaceuticals Ltd — Board Meeting, 05-08-2025: Board Meeting

The company's board has approved its financial results for the quarter ended June 30, 2025. Key operational changes include the shifting of its corporate office. The board also appointed Mr. Ravi Thakor as an Additional Non-Executive Non-Independent Director, and Mr. Yogeshkumar Prajapati and Mrs. Bhumika Pradhan as Additional Non-Executive Independent Directors. These appointments follow the resignations of Mr. Suraj Chagan Solanki and Mrs. Deepika Krishnan Iyer. Consequently, the Audit, Nomination & Remuneration, and Stakeholders Relationship Committees have been reconstituted, strengthening the board's governance structure and bringing in new perspectives.